Skip to content
About
Expand
About
Lars Edvinsson
Board of directors
Management
Scientific advisory board
Research & development
Expand
Pioneering research
Mechanism of action
EDV2209
Results – Completed phase 1b/2a study
Clinical and regulatory path forward for the Phase 2b SAH study
Orphan Drug
Publications
Collaborative partners
Pipeline
Expand
Pipeline
SAH – Subarachnoid haemorrhage
FI – Focal ischemic stroke
GI – Global cerebral ischemia
Investors
Expand
Strategy
Milestones
Market Overview
Patent
Shareholders
News
Toggle Menu
EIC
XXX
Contact
Medicon Village
223 81 Lund. Sweden
info@edvince.com
About
Toggle child menu
Expand
About
Lars Edvinsson
Board of directors
Management
Scientific advisory board
Research & development
Toggle child menu
Expand
Pioneering research
Mechanism of action
EDV2209
Results – Completed phase 1b/2a study
Clinical and regulatory path forward for the Phase 2b SAH study
Orphan Drug
Publications
Collaborative partners
Pipeline
Toggle child menu
Expand
Pipeline
SAH – Subarachnoid haemorrhage
FI – Focal ischemic stroke
GI – Global cerebral ischemia
Investors
Toggle child menu
Expand
Strategy
Milestones
Market Overview
Patent
Shareholders
News
